Sign Up
SB 200 Maryland Senate · 2022 Regular Session

Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data

Bill status signed all 5 stages cleared
Introduction
Oct 2021
Committee Review
Apr 2022
Senate Passage
Apr 2022
House of Delegates Passage
Apr 2022
Signed into Law
Apr 2022
Introduced Oct 5, 2021 Signed Apr 21, 2022
Floor votes · Senate Feb 10, 2022 · House of Delegates Apr 3, 2022

How they voted

40–0
Passed · 2 other
Total votes 42
Feb 10, 2022
D Democratic28
26 Yea 2
92% Yea
R Republican14
14 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
15
Key actions
9
Committee
6
Apr 21, 2022
Signed into law
Approved by the Governor - Chapter 224
executive
Apr 11, 2022
Upper · Passed
Returned Passed
upper
Apr 11, 2022
Lower · Passed
Third Reading Passed
lower
Apr 8, 2022
Lower · Passed
Favorable Adopted Second Reading Passed
lower
Apr 7, 2022
Lower · Passed
Favorable Report by Health and Government Operations
lower
Apr 3, 2022
House Of Delegates · Passed
House of Delegates Vote: pass (118-0-6)
house of delegates
Feb 17, 2022
Committee
Referred Health and Government Operations
lower
Feb 10, 2022
Upper · Passed
Third Reading Passed
upper
Feb 8, 2022
Upper · Passed
Favorable Adopted
upper
Feb 7, 2022
Upper · Passed
Favorable Report by Finance
upper
Jan 12, 2022
Committee
First Reading Finance
upper
Oct 5, 2021
Introduced
Pre-filed
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.